Breast cancer breakthrough
AUSTRALIAN researchers have developed a new drug to treat an aggressive form of breast cancer that works by starving the cancer cells of nutrients to stop them from multiplying.
If successful in the lab, clinical trials could start within the next few years, offering hope to women diagnosed with triple-negative breast cancer (TNBC). TNBC accounts for about 15 per cent of all breast cancer cases and typically has poorer survival outcomes.
Chemotherapy is the standard therapy but there are no targeted therapies when it fails.